1. Lithium-induced Clock Gene Expression in Lymphoblastoid Cells of Bipolar Affective Patients
- Author
-
L. Schnetzler, Lena Weißflog, S. Schreck, M. Hilscher, R. Schwarz, C. Ziegler, Andreas Reif, Maria Neuner, and Sarah Kittel-Schneider
- Subjects
Male ,medicine.medical_specialty ,Bipolar Disorder ,Lithium (medication) ,Circadian clock ,Gene Expression ,Pilot Projects ,Biology ,Cell Line ,Antimanic Agents ,Circadian Clocks ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Circadian rhythm ,Bipolar disorder ,Lymphoblast ,General Medicine ,Cell cycle ,medicine.disease ,DNA-Binding Proteins ,CLOCK ,Psychiatry and Mental health ,Endocrinology ,Cell culture ,Female ,Lithium Chloride ,Transcription Factors ,medicine.drug - Abstract
Introduction: Disturbances of circadian rhythms occur in all episodes of bipolar disorder (BD). Lithium, as gold-standard in the maintenance treatment of BD, is known to influence circadian processes. Methods: In a pilot study lymphoblastoid cell lines (LCLs) were generated from 8 BD patients and 6 healthy controls. The LCLs were treated with lithiumchloride (LiCl) for 3 weeks. Cell cycles were then synchronized and expressional analysis by quantitative Real Time PCR was done. Results: BD and controls differed in the period length regarding DBP (albumin D-box binding protein) expression and DBP expression was also influenced by lithium treatment. Furthermore, baseline DBP expression was significantly different between non-treated BD and healthy controls. None of the other analyzed circadian genes showed to be influenced by chronic lithium treatment or to be differentially regulated due to the diagnosis. Discussion: We here show that chronic lithium treatment of LCLs leads to decreased expression of the clock gene DBP, rendering DBP a lithium-regulated gene. We could confirm the role of the circadian clock as well in lithium mode of action as in the pathomechanisms of BD although future studies with a greater number of participants and cell lines are needed.
- Published
- 2015